Drug Shortage Report for LOSARTAN HCT
Report ID | 120609 |
Drug Identification Number | 02388987 |
Brand name | LOSARTAN HCT |
Common or Proper name | LOSARTAN HCT |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | DORMANT |
Active Ingredient(s) | LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE |
Strength(s) | 100MG 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-03-15 |
Actual start date | |
Estimated end date | 2021-04-05 |
Actual end date | 2021-03-22 |
Shortage status | Resolved |
Updated date | 2021-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2021-03-23 | French | Compare |
v21 | 2021-03-23 | English | Compare |
v20 | 2021-03-16 | English | Compare |
v19 | 2021-02-16 | French | Compare |
v18 | 2021-02-16 | English | Compare |
v17 | 2021-02-16 | English | Compare |
v16 | 2021-01-26 | French | Compare |
v15 | 2021-01-26 | English | Compare |
v14 | 2021-01-26 | English | Compare |
v13 | 2020-12-23 | French | Compare |
v12 | 2020-12-23 | English | Compare |
v11 | 2020-12-22 | English | Compare |
v10 | 2020-12-03 | French | Compare |
v9 | 2020-12-03 | English | Compare |
v8 | 2020-12-01 | English | Compare |
v7 | 2020-11-13 | French | Compare |
v6 | 2020-11-13 | English | Compare |
v5 | 2020-10-27 | English | Compare |
v4 | 2020-08-04 | French | Compare |
v3 | 2020-08-04 | English | Compare |